 |
|
 |
|
 |
|
|
EJNR, The European Journal for Nutraceutical Research is a web based international scientific peer reviewed journal portal, dedicated to the rapid publication of research in the field of Nutraceuticals, offering a rich and diverse range of research material.
|
|
 |
|
|
|
|
 |
|
|
|
|
Plant base medical research covers ingredients and products reaching from, functional foods, dietary supplements, cosmeceuticals to herbal products including herbal medicinal products, etc. that have nutritional, physiological, pharmacological or cosmetic effects in the area of health, beauty and wellness.
» MORE DETAILS... |
|
|
|
|
|
|
eUROPEAN JOURNAL FOR NUTRACEUTICAL RESEARCH |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
| |
 |
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
Virucidal activity of black elderberry extract (Sambucol® Original and Immuno Forte) against attenuated swH1N1 Swine Flu
A. Catchpole, S Balasingam, London Bioscience Innovation Centre, 2 Royal College Street London NW1 0NH* Q. Adil, Pharmacare Laboratories Pty Ltd, NSW, Australia**
Abstract
This in vitro study determined the viral efficacy of 38% black elderberry extract presented as Sambucol® Original and Sambucol® Immuno Forte against Influenza NIBRG – 121 (attenuated H1N1) at concentrations that did not exhibit toxicity. Both formulations were tested and found to be non-toxic at 25% (v/v) concentration.
The virucidal activity of both formulations was measured at the 25% (v/v) concentration level over 5, 10, 30 and 60 minutes incubation period. Results showed that both formulations were able to reduce the viral titre of Influenza NIBRG-121 (H1N1) virus by 68.37% over 10, 30 and 60 minute time points when compared to the control virus titre. Additionally Sambucol® Original extract also showed significant anti-viral activity after 5 minutes. These data reinforce the established antiviral activity of black elderberry when presented as Sambucol® Original and Immuno Forte as a 38% extracted formulation.
Stabilised allicin (Allisure®) A unique natural
antimicrobial agent
Norman J Bennett, B.Sc.(Hons.), C.Eng, MICE, Allicin International Limited
Peter D Josling, B.Sc.(Hons.), Allicin International Limited
Dr Ron Cutler, DMS, PhD, MSc (London), MSc (Cranfield), BSc, MIBiol, CIBiol, CSc. FIBMS, Principal Lecturer, Infectious Diseases and Pathology, School of Health and Bioscience, Department of Life Biosciences, University of East London
Abstract
This paper describes the main biological properties of stabilised allicin (Diallyl thiosulfinate ) and confirmed activity against multi-drug resistant bacterial infections such as methicillin resistant staphylococcus aureus (MRSA).
Several case studies are reported to show how stabilised allicin in capsule, cream, and liquid formulations can be used to resolve existing MRSA infections that were completely resistant to pharmaceutical antibiotic treatment. Patients generally found the treatments very acceptable and free from side effects.
Clearly, stabilised allicin formulations offer a safe natural alternative or addition to drug treatment and are seen to be very effective in terms of both resolution of infection and wound healing capabilities.
To aquire this Title complete the form below and submit. A member of the Journal Team will contact you shortly (« compulsory fields).
|
|
|
|
|
|
